HANDOK Inc.

KOSE:A002390 Voorraadrapport

Marktkapitalisatie: ₩187.9b

HANDOK Inkomsten in het verleden

Verleden criteriumcontroles 0/6

HANDOK's earnings have been declining at an average annual rate of -59.7%, while the Pharmaceuticals industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 2.9% per year.

Belangrijke informatie

-59.7%

Groei van de winst

-60.0%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie11.3%
Inkomstengroei2.9%
Rendement op eigen vermogen-10.5%
Nettomarge-6.6%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

Is HANDOK (KRX:002390) A Risky Investment?

Oct 16
Is HANDOK (KRX:002390) A Risky Investment?

Is HANDOK (KRX:002390) Using Too Much Debt?

Jul 01
Is HANDOK (KRX:002390) Using Too Much Debt?

HANDOK Inc.'s (KRX:002390) 27% Share Price Surge Not Quite Adding Up

May 28
HANDOK Inc.'s (KRX:002390) 27% Share Price Surge Not Quite Adding Up

Is HANDOK Inc.'s (KRX:002390) 1.0% Dividend Worth Your Time?

Apr 01
Is HANDOK Inc.'s (KRX:002390) 1.0% Dividend Worth Your Time?

How Much Of HANDOK Inc. (KRX:002390) Do Insiders Own?

Mar 15
How Much Of HANDOK Inc. (KRX:002390) Do Insiders Own?

HANDOK (KRX:002390) Has A Somewhat Strained Balance Sheet

Feb 28
HANDOK (KRX:002390) Has A Somewhat Strained Balance Sheet

Did You Miss HANDOK's (KRX:002390) 21% Share Price Gain?

Feb 13
Did You Miss HANDOK's (KRX:002390) 21% Share Price Gain?

HANDOK Inc. (KRX:002390) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Jan 31
HANDOK Inc. (KRX:002390) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

We're Not So Sure You Should Rely on HANDOK's (KRX:002390) Statutory Earnings

Jan 18
We're Not So Sure You Should Rely on HANDOK's (KRX:002390) Statutory Earnings

Here's Why I Think HANDOK (KRX:002390) Might Deserve Your Attention Today

Jan 05
Here's Why I Think HANDOK (KRX:002390) Might Deserve Your Attention Today

Should HANDOK Inc. (KRX:002390) Be Part Of Your Dividend Portfolio?

Dec 23
Should HANDOK Inc. (KRX:002390) Be Part Of Your Dividend Portfolio?

What Kind Of Investors Own Most Of HANDOK Inc. (KRX:002390)?

Dec 10
What Kind Of Investors Own Most Of HANDOK Inc. (KRX:002390)?

HANDOK (KRX:002390) Has A Somewhat Strained Balance Sheet

Nov 27
HANDOK (KRX:002390) Has A Somewhat Strained Balance Sheet

Opbrengsten en kosten

Hoe HANDOK geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

KOSE:A002390 Opbrengsten, kosten en inkomsten (KRW Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 24510,847-33,498119,79023,936
31 Mar 24523,148-26,699118,17227,586
31 Dec 23522,741-28,797114,44828,672
30 Sep 23532,175-5,603112,64128,183
30 Jun 23553,5201,465112,48828,233
31 Mar 23545,0485,990110,12825,038
31 Dec 22543,75910,684110,82123,995
30 Sep 22547,5443,340110,83723,304
30 Jun 22533,912-2,796108,83623,553
31 Mar 22525,6771,736107,86723,176
31 Dec 21517,6413,295105,64422,879
30 Sep 21509,68415,001109,20623,203
30 Jun 21507,94731,457108,71322,044
31 Mar 21506,78429,556109,24321,105
31 Dec 20503,61226,960108,81620,135
30 Sep 20500,63931,426107,47518,168
30 Jun 20486,59733,993107,72418,028
31 Mar 20478,08027,508106,77219,062
31 Dec 19473,00034,929107,71119,240
30 Sep 19460,80516,348107,07420,611
30 Jun 19457,5783,897104,68020,193
31 Mar 19453,7189,409105,36920,197
31 Dec 18446,7317,990104,57121,119
30 Sep 18423,15415,959100,46421,634
30 Jun 18420,58515,988102,71023,209
31 Mar 18416,71013,192102,95323,029
31 Dec 17417,9704,869102,56522,449
30 Sep 17427,730-2,716102,45621,564
30 Jun 17414,775-8,991101,06819,977
31 Mar 17409,977-9,74798,48319,674
31 Dec 16396,134-6,45497,74518,472
30 Sep 16392,8411,72697,54317,730
30 Jun 16383,8771,31695,50018,386
31 Mar 16365,5872,40692,22917,171
31 Dec 15358,448-1,68787,80918,809
31 Dec 14348,3111,47381,80815,629
31 Dec 13327,93612,31069,57117,532

Kwaliteitswinsten: A002390 is currently unprofitable.

Groeiende winstmarge: A002390 is currently unprofitable.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: A002390 is unprofitable, and losses have increased over the past 5 years at a rate of 59.7% per year.

Versnelling van de groei: Unable to compare A002390's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: A002390 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (21.9%).

Rendement op eigen vermogen

Hoge ROE: A002390 has a negative Return on Equity (-10.46%), as it is currently unprofitable.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y